SpineGuard has received certification from the Brazilian governmental regulatory authority ANVISA (Agência Nacional de Vigilância Sanitária) following a three-day inspection in Paris.
This certification by ANVISA has recently become the mandatory precursor to register new medical devices for marketing in Brazil.
“This ANVISA certification consolidates our regulatory position in Brazil, an important market for SpineGuard,” comments Pierre Jérôme, co-founder and chief executive officer of SpineGuard. “It will allow us to initiate the registration process for the curved, cannulated and XS versions of PediGuard in this large market.”
